As of January 22, 2025, Nkarta (NKTX) has a market cap of $0.18 billion USD. According to our data, Nkarta is ranked No.7232 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.18 B |
-0.40%
|
Dec 31, 2024 | $0.18 B |
-62.27%
|
Dec 29, 2023 | $0.47 B |
10.18%
|
Dec 30, 2022 | $0.42 B |
-60.98%
|
Dec 31, 2021 | $1.08 B |
-75.03%
|
Dec 31, 2020 | $4.34 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Sana Biotechnology
SANA
|
$0.78 B |
0.000 M
|
USA
|
Market Cap | = | NKTX Stock Price | * | NKTX Shares Outstanding |
= | $2.48 | * | 70.57 M | |
= | $0.18 B |